Senior insider sale
Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$6.73M
62.77K shares
What this filing means
SMITH HUNTER C plans to sell 62.77K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $6.73M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/31/2026ACC: 0001950047-26-008867
Officer· Chief Financial Officer
Since Mar 2026
62.77K
Shares to sell
$6.73M
Approx. market value
62.77K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
8/31/2026
57.19KRestricted Stock Units
N/A
2/1/2026
5.59KTotal acquired62.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/31/2026 | Exercise of Stock Options Cash | 57.19K | — |
2/1/2026 | Restricted Stock Units N/A | 5.59K | — |
| Total | 62.77K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
62.77K
Market value
$6.73M
8/31/2026
Total
Units
62.77K
Value
$6.73M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/31/2026 | 62.77K | $6.73M | NASDAQ | Planned |
| Total | 62.77K | $6.73M | ||